GC3111

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC3111, covering 2020-01-23 to 2020-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults [Phase 2]